Quinagolide is a D2 dopamine receptor agonist which may be used to treat hyperprolactinaemia.
Quinagolide is as effective as bromocriptine in reducing prolactin levels and is as well tolerated as once-daily bromocriptine.
Quinagolide is more expensive than the other dopmaine receptor agonists and is probably worth considering only in patients resistant to bromocriptine and cabergoline (1).
- Drug and Therapeutics Bulletin 1995; 33(9):65-7.
Last reviewed 01/2018